Cansino Biologics Inc. (688185)

Cansino Biologics Inc. (688185)

$ 10

Foreign Investors Rating

English Version

Date : 15 Jan 2021


CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company’s products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner